Pascal Irrgang

878 total citations
9 papers, 87 citations indexed

About

Pascal Irrgang is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Pascal Irrgang has authored 9 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Pascal Irrgang's work include SARS-CoV-2 and COVID-19 Research (3 papers), Respiratory viral infections research (3 papers) and Immune Cell Function and Interaction (3 papers). Pascal Irrgang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Respiratory viral infections research (3 papers) and Immune Cell Function and Interaction (3 papers). Pascal Irrgang collaborates with scholars based in Germany, France and United States. Pascal Irrgang's co-authors include Matthias Tenbusch, Dennis Lapuente, Philipp Steininger, Jürgen Held, Kilian Schober, Koray Taşçılar, Christian Bogdan, Andreas E. Kremer, Klaus Korn and Klaus Überla and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Frontiers in Immunology.

In The Last Decade

Pascal Irrgang

9 papers receiving 85 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Irrgang Germany 5 49 29 15 13 12 9 87
Till Koch Germany 5 70 1.4× 12 0.4× 8 0.5× 14 1.1× 9 0.8× 12 94
Ke Lin China 7 42 0.9× 13 0.4× 16 1.1× 28 2.2× 16 1.3× 11 98
Lance Baldo United States 4 78 1.6× 27 0.9× 5 0.3× 18 1.4× 22 1.8× 10 114
Selina Gierer United States 5 34 0.7× 29 1.0× 10 0.7× 17 1.3× 9 0.8× 16 99
Alexander Anderson United States 4 33 0.7× 24 0.8× 15 1.0× 25 1.9× 2 0.2× 5 73
Benjamin Chung United States 2 105 2.1× 15 0.5× 14 0.9× 16 1.2× 6 0.5× 2 123
Shane Cloney-Clark Australia 7 80 1.6× 33 1.1× 21 1.4× 20 1.5× 3 0.3× 12 111
Victoria Giffin United States 2 103 2.1× 14 0.5× 13 0.9× 16 1.2× 6 0.5× 3 122
Charles Gleason United States 4 58 1.2× 22 0.8× 6 0.4× 49 3.8× 4 0.3× 7 97
Marcelino Padilla Netherlands 2 57 1.2× 21 0.7× 11 0.7× 16 1.2× 12 1.0× 3 74

Countries citing papers authored by Pascal Irrgang

Since Specialization
Citations

This map shows the geographic impact of Pascal Irrgang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Irrgang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Irrgang more than expected).

Fields of papers citing papers by Pascal Irrgang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Irrgang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Irrgang. The network helps show where Pascal Irrgang may publish in the future.

Co-authorship network of co-authors of Pascal Irrgang

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Irrgang. A scholar is included among the top collaborators of Pascal Irrgang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Irrgang. Pascal Irrgang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Irrgang, Pascal, Ralf J. Rieker, Carol I. Geppert, et al.. (2025). Inflammatory conditions shape phenotypic and functional characteristics of lung-resident memory T cells in mice. Nature Communications. 16(1). 3612–3612. 2 indexed citations
2.
Irrgang, Pascal, Michael Rückert, Carol I. Geppert, et al.. (2024). Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases. Journal for ImmunoTherapy of Cancer. 12(3). e008652–e008652. 11 indexed citations
3.
Irrgang, Pascal, et al.. (2024). Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus. npj Vaccines. 9(1). 205–205. 3 indexed citations
4.
Irrgang, Pascal, et al.. (2024). Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus. Frontiers in Immunology. 15. 1376395–1376395. 1 indexed citations
5.
Irrgang, Pascal, et al.. (2023). Mucosal vaccination with an adenoviral vector vaccine protects against pulmonary breast cancer metastasis by robust induction of tissue-resident memory T-cells in the lung. The Journal of Immunology. 210(Supplement_1). 145.22–145.22. 1 indexed citations
6.
Irrgang, Pascal, et al.. (2022). Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity. Frontiers in Immunology. 13. 920256–920256. 14 indexed citations
7.
Held, Jürgen, Koray Taşçılar, Philipp Steininger, et al.. (2021). Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®). Vaccines. 9(10). 1063–1063. 26 indexed citations
8.
Steininger, Philipp, Pascal Irrgang, Klaus Korn, et al.. (2021). Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. European Journal of Clinical Microbiology & Infectious Diseases. 40(9). 1983–1997. 6 indexed citations
9.
Lapuente, Dennis, Pascal Irrgang, Antonia Sophia Peter, et al.. (2020). Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases. 40(4). 751–759. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026